Skip to main content
Fig. 5 | Journal of Ovarian Research

Fig. 5

From: MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer

Fig. 5

The influence of LINC01296/ miR-29c-3p axis on EMT pathway of OC cells. (a-d) The result of western blot analysis demonstrated that down-regulation of LINC01296 inhibited the EMT of OC cells, while inhibition of miR-29c-3p promoted the EMT of OC cells. When SKOV3 and OVCAR3 cells were treated with miR-29c-3p inhibitor plus si-LINC01296, the EMT was markedly suppressed compared with the miR-29c-3p inhibitor group. **P < 0.01 vs. control group, ##P < 0.01 vs. miR-29c-3p inhibitor group

Back to article page